Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tretinoin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 86 for your search:
Start Over
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: Pethema LPA-99 protocol, NCT00465933
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LAP-R2007, NCT00504764
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242
Phase III Randomized Trial of Tretinoin vs ARA-C/DNR as Induction Therapy and of Tretinoin vs Observation as Maintenance Therapy for Patients with Previously Untreated Promyelocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: E-2491, ALSG-91/M5, CAN-NCIC-AL2, CCG-2911, CLB-9191, POG-9220, SWOG-9129, EST-2491, INT-0129, E2491, BL10
Phase III Randomized Study of IFN-A vs IFN-A/TRA in Patients with CML in Chronic Phase (Summary Last Modified 12/92)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-92017A1, NCI-V92-0096
Phase III Trial in Acute Promyelocytic Leukemia Patients
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: APL0406, GIMEMA-SAL-APL0406, EUDRACT-2006-006188-22, GIMEMA-DSL-APL0406, EU-20725, NCT00482833
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0521, U10CA032102, SWOG-S0521, NCT00492856
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 and over
Sponsor: Other
Protocol IDs: AMLSG06-04, NCT00151255
Phase III Study of Risk-Adapted Induction Chemotherapy, Risk-Adapted Consolidation Combination Chemotherapy Including Arsenic Trioxide, and Maintenance Combination Chemotherapy in Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: COG-AAML0631, COG-AAML0631, AAML0631, NCT00866918
Differentiation Induction in Acute Myelogenous Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: REK-Vestnr21503, NCT00175812
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06-054, MSKCC-06054, NCT00382200
Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0624, NCI-2014-01098, NCT01985477
Phase II Study of Tretinoin (All-trans-Retinoic Acid) in Patients with Acute Promyelocytic Leukemia (Summary Last Modified 06/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-90037, NCI-V90-0105
Phase II Trial of Tretinoin in Patients with Refractory Germ Cell Tumors (Summary Last Modified 08/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MSKCC-91020A1, NCI-T91-0066C, T91-0066
Phase II Study of Tretinoin/Idarubicin Followed by Idarubicin/POMP (MP/VCR/MTX/PRED) in Patients with Newly Diagnosed Acute Promyelocytic Leukemia (Summary Last Modified 04/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MDA-DM-91024, NCI-T91-0042D, T91-0042
Phase II Study of Tretinoin in the Treatment of Intermediate- and High-Risk Chronic Lymphocytic Leukemia (Summary Last Modified 09/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-91018A1, NCI-V91-0074
Phase II Study of TRA in Patients with Malignant Gliomas (Summary Last Modified 04/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCI-9110, NCI-T91-0148O, T91-0148
Phase II Pilot Study of TRA and Antiretroviral Therapy in HIV-Related Kaposi's Sarcoma (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18 to less than 70
Sponsor: NCI
Protocol IDs: LAC-USC-17K911, NCI-T91-0126D, T91-0126
Phase II Study of TRA in Patients with Extensive Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: UPCC-2591, NCI-T91-0177D, T91-0177
Phase II Study of TRA in Metastatic non-Small Cell Lung Cancer (Summary Last Modified 01/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: UPCC-1591, NCI-T91-0175D, T91-0175
Phase II Study of TRA in Chronic Myelogenous Leukemia (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-90060, NCI-T90-0191D, T90-0191
Phase II Trial of TRA in Patients with Hormone-Resistant Adenocarcinoma of the Prostate (Summary Last Modified 03/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-91122, NCI-T91-0139C, T91-0139
Phase II Pilot Study of TRA in Patients with Relapsed or Refactory Acute Promyelocytic Leukemia (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MSKCC-91110, NCI-V91-0171
Start Over